{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:10:31Z","timestamp":1790003431589,"version":"4.0.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000045","name":"Aetna Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006785","name":"Google","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jacl.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T12:56:03Z","timestamp":1536929763000},"page":"1383-1389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["The spectrum of type III hyperlipoproteinemia"],"prefix":"10.1016","volume":"12","author":[{"given":"Allan D.","family":"Sniderman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Thanassoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 J.","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Couture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacl.2018.09.006_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJM196701052760107","article-title":"Fat transport in lipoproteins--an integrated approach to mechanisms and disorders","volume":"276","author":"Fredrickson","year":"1967","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jacl.2018.09.006_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.7326\/0003-4819-82-2-158","article-title":"The biochemical, clinical, and genetic features of type III hyperlipoproteinemia","volume":"82","author":"Morganroth","year":"1975","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.jacl.2018.09.006_bib3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11883-014-0440-2","article-title":"Hyperlipoproteinemia type 3: the forgotten phenotype","volume":"16","author":"Hopkins","year":"2014","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"10.1016\/j.jacl.2018.09.006_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/10408363.2013.870526","article-title":"Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E","volume":"51","author":"Marais","year":"2014","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"4","key":"10.1016\/j.jacl.2018.09.006_bib5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacl.2007.07.006","article-title":"Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B","volume":"1","author":"Sniderman","year":"2007","journal-title":"J Clin Lipidol"},{"issue":"11","key":"10.1016\/j.jacl.2018.09.006_bib6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/ncpendmet0982","article-title":"A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias","volume":"4","author":"De Graaf","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.jacl.2018.09.006_bib7","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1373\/clinchem.2018.287037","article-title":"Quantifying atherogenic lipoproteins: current and future challenges in the Era of personalized medicine and very low concentrations of LDL cholesterol. A consensus statement from EAS and EFLM","volume":"64","author":"Langlois","year":"2018","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.jacl.2018.09.006_bib8","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"34","author":"Havel","year":"1955","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.jacl.2018.09.006_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/clinchem\/24.6.853","article-title":"Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein","volume":"24","author":"Albers","year":"1978","journal-title":"Clin Chem"},{"issue":"1 Pt 2","key":"10.1016\/j.jacl.2018.09.006_bib10","first-page":"I12","article-title":"Patterns of dyslipoproteinemia in selected North American populations. The lipid research clinics program prevalence study","volume":"73","author":"LaRosa","year":"1986","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacl.2018.09.006_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.atherosclerosis.2009.05.016","article-title":"Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study","volume":"207","author":"Hopkins","year":"2009","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.jacl.2018.09.006_bib12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jacc.2004.11.062","article-title":"Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease","volume":"45","author":"Hopkins","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jacl.2018.09.006_bib13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jacl.2013.05.003","article-title":"Resequencing the APOE gene reveals that rare mutations are not significant contributory factors in the development of type III hyperlipidemia","volume":"7","author":"Evans","year":"2013","journal-title":"J Clin Lipidol"},{"issue":"9623","key":"10.1016\/j.jacl.2018.09.006_bib14","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(08)60313-X","article-title":"Age as a modifiable risk factor for cardiovascular disease","volume":"371","author":"Sniderman","year":"2008","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.jacl.2018.09.006_bib15","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.jacc.2017.08.006","article-title":"A test in context: lipid profile, fasting versus nonfasting","volume":"70","author":"Nordestgaard","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418304045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418304045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:34:35Z","timestamp":1761831275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287418304045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1933287418304045"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2018.09.006","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The spectrum of type III hyperlipoproteinemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}